A reliable overview of data on the prevalence of Chlamydia trachomatis (CT) in Russia is lacking and needed. All the available data on CT prevalence were analyzed in a systematic literature review on CT prevalence in Russia, strengthened with data from the multicenter study among 1263 people in the second-largest Russian megalopolis, St. Petersburg, testing for CT DNA in urethral, anal, cervical and prostate samples. A total of 10 articles met the inclusion criteria. The overall average prevalence of genital CT infections in Russian populations ranged from 2.9% to 33%. Risk factors included being symptomatic (P = 0.004; in men P < 0.001), being younger than 30 years (P = 0.001) and being a man who has sex with men (MSM) (P = 0.0084). Main limitations included the lack of studies in MSM. CT prevalence was higher in the groups where urethral and prostate secretion samples were pooled (5.2%-7.3% vs 3.2% in the urethra only). The data on CT prevalence in a range of Russian populations are analyzed and reported. Prostate secretions represent an additional sampling material for the study of CT infection in men. CT detection in some settings in St. Petersburg yielded levels of reliability comparable with internationally available tests. The initiation of screening programs for Chlamydia infections in Russia should be considered.
INTRODUCTION
Chlamydia trachomatis (CT) is the most commonly detected bacterial sexually transmitted infection (STI) worldwide (ECDC 2016; WHO 2016; CDC 2017) . Although most CT infections are asymptomatic (Detels et al. 2011; Clarivet et al. 2014) , CT infection is a major cause of pelvic inflammatory diseases, ectopic pregnancy and infertility (WHO 2016) and increases the risk of HIV acquisition (Wasserheit 1992; Stamm 1999; Chesson and Pinkerton 2000; Røttingen, Cameron and Garnett 2001) . The Joint United Nations Programme on HIV/AIDS (UNAIDS) in 2010 reported that the HIV prevalence in Russia is 1% or higher, with the growing HIV epidemic predominantly affecting drug users, sex workers and vulnerable young people (UNAIDS 2010) . However, reliable data on the incidence and prevalence of CT infections in the country are very limited (Smelov et al. 2009 ). There is currently no CT vaccine; therefore, early detection and reliable diagnosis are important, because CT infection can be treated with antibiotics.
In Russia, genital CT infection is a reportable STI, and for decades a state-controlled network of outpatient dispensaries for skin and venereal diseases was responsible for the diagnosis and treatment of STI. However, the collapse of the Soviet Union and economic liberalization in the 1990s changed the previously centralized healthcare model into a mixed configuration, with private and state financing. This resulted in the current situation, where the exact number of different providers of venereological services (dispensaries, dermato-venereologists at larger general hospitals or outpatient clinics, etc.) is unknown (Domeika et al. 2008) . Evaluations of some of the Russian nucleic acid amplification tests (NAATs) have shown that these tests yield similar levels of reliability compared with internationally available tests (Shipitsyna et al. 2009 (Shipitsyna et al. , 2012 Smelov et al. 2009 ). However, the available data on CT prevalence in Russia have been obtained only from small, high-risk populations, such as young (16-24 years) female university students (Khryanin, Reshetnikov and Vlaspolder 2007) , male patients with acute urethritis (Taylor-Robinson et al. 2009 ) or young (15-19 years) people (Shipitsyna et al. 2013) .
Extended knowledge on the prevalence of CT among diverse populations in this large and diversely populated country is of great importance. In addition to their value for epidemiological purposes or transmission studies, such analyses would have a direct clinical relevance and could be of significant help to public health policy makers. Improved control of genital CT infections, i.e. by screening programs, could prevent the drop in fertility in Russia with the process of depopulation (Grigulevich 2012) and slow down the transmission of STIs, in particular the growing HIV epidemic (UNAIDS 2010) .
This study had two components. First, we performed a systematic literature review and analyzed the available data on CT prevalence in Russia. Second, because data on the prevalence of CT infections in the country are limited, additional data were provided from a multicenter study performed in St. Petersburg in 2006 . These data were then used to assess the need to support the initiation of screening and prevention programs for CT infections.
MATERIALS AND METHODS

Systematic literature review
Articles and studies to be included in the review were obtained from the main scientific databases, PubMed and Embase, using the Medical Subject Headings (MeSH) terms "Chlamydia trachomatis" and "Russia". In addition, Google Scholar was screened using the same search criteria to include articles from nonindexed journals and "gray literature". The literature was limited to articles in English and Russian and to articles where a full-text version could be accessed. The initial search was performed by screening the databases for all available articles until January 2017. We checked for duplicates among articles obtained from the databases, and all duplicates were excluded. Articles were included for review if they presented results from CT screening in defined populations in Russia. Articles were excluded if they featured testing on previously diagnosed CT-positive patients, tested the sensitivity of drugs or described laboratory techniques or basic research on CT infection. In addition, the references of each article included for analysis were screened for potential additional articles on the subject. Men and women were eligible for the study if they were at least 18 years old. All participants were evaluated with a detailed medical history and physical examination, including gynecological examination in women and digital rectal examination in men, during which the expressed prostate secretion (EPS) was collected. In addition, participants were asked questions about lifestyle and sexual behavior factors, such as the age at sexual debut, the number of lifetime sexual partners, sexual behavior and history of STIs. Men who reported having had sex (anal or oral) with other men during their lifetime were categorized as men who have sex with men (MSM). Men who reported having had sex with only women were classified as men who have sex with women (MSW). To avoid decreasing the response rate, the questions about whether a man had ever had sex (anal or oral) with other men during his lifetime were asked before sampling, during the face-to-face interview by a single physician, who had been trained during the UNESCO-ASM Travel Award at the STI Outpatient clinic in Amsterdam. The replies were coded, and all participants were informed that the information would be confidential and not provided to any third parties. No data about same-sex sexual preferences were collected in women. No information about proper use of condoms was collected, because anyone seeking STI testing was considered to have experienced failure of condom use at least once. All participants provided blood samples for obligatory testing for HIV and Treponema pallidum antibodies. All anogenital samples obtained were tested with polymerase chain reaction (PCR) assays for CT, Neisseria gonorrhoeae, Trichomonas vaginalis and herpes simplex virus (types 1 and 2) in St. Petersburg.
Sampling procedures for CT testing
Before sampling, male study participants in Group 1 were instructed to abstain from any form of sex for 3-5 days and from urination for 3-4 h. The study physician obtained urethral and prostate (EPS) samples in parallel for a study on human papillomavirus (HPV) (Smelov et al. 2013) but pooled them for the current study on CT(Groups 1A and 1B) or sampled only the distal part of the urethra where EPS was not collected (Group 1C). In MSM, the anal canal was sampled with a swab wetted in phosphate-buffered saline, and the swab was then rinsed in a tube containing 1000 μl of phosphate-buffered saline. In women (Group 2), only cervical samples were obtained, as previously described (Shalepo et al. 2006) , and were also rinsed in a tube containing 1000 μl of phosphate-buffered saline. No samples were prospectively collected in Group 3, as the samples had been previously analyzed and only the clinical data and CT results were collected and used.
After the material was obtained, all tubes containing the samples were immediately placed in a refrigerator at 4
• C and at the end of the day were transferred into a freezer and stored at −20
• C prior to transportation and testing for CT infection in
Amsterdam.
Detection of CT
In the samples from men in Group 1, the data in the presence of CT previously detected in St. Petersburg with culture and domestic PCR assays (Shalepo et al. 2006; Smelov et al. 2009 ) were available. Briefly, conventional PCR (Lytech, Moscow, Russia) was applied to test the urethral samples in one laboratory, and realtime PCR (Central Research Institute of Epidemiology, Moscow, Russia) was applied to test the pooled urethral and EPS samples in another laboratory. These results were later confirmed in Amsterdam, by additional testing for CT DNA at the Laboratory of Immunogenetics (VU University Medical Center, Amsterdam, the Netherlands) as previously described in the CT serovar determination study (Smelov et al. 2009: 209) . The results from a commercially available real-time PCR assay (TaqMan, Applied Biosystems, USA) (Morré et al. 1999) were additionally confirmed with the CE-IVD certified Presto CT-NG Assay (Goffin Molecular Technologies, Beek, the Netherlands) (Schuurs et al. 2013; de Waaij et al. 2015) . In the cervical samples from women in Group 2, the presence of CT was detected by the PCR assay (Lytech, Moscow, Russia) in St. Petersburg and confirmed in Amsterdam (Presto CT-NG Assay, Goffin Molecular Technologies, Beek, the Netherlands).
In the semen samples from men in Group 3, the data for this study were collected about the previous semen analysis and detection of CT DNA in the semen by PCR (Lytech, Moscow, Russia) in several commercial laboratories through St. Petersburg and analyzed. 
Ethics
Statistical analysis
The chi-square or Fisher exact test was used to evaluate CT infection prevalence; 95% confidence intervals (95%CI) were calculated for all proportions, risk factors for CT infection, and logistic regression was conducted to determine factors associated with CT prevalence in a cross-sectional analysis by using GraphPad Instat statistical software (version 3.06; GraphPad Software Inc.).
RESULTS
Literature search
The initial literature search yielded 33 original articles, based on screening of abstracts. A total of 24 articles were excluded from the review. Of those, eight studies featured drug sensitivity testing performed on CT-positive samples, seven articles described laboratory techniques, three articles provided results on serotypes of CT samples and two articles provided information on multilocus sequence typing of CT-positive samples. In three other articles, we were not able to identify crucial information, such as the testing methods and the location of the study, and one article used PCR tests commercially available in Russia on a Swedish study population. The screening of the references of the initially included articles led to the inclusion of one additional article that met the requirements of the review. The results of the review of selected articles are summarized in the flowchart (Fig. 1) . A total of 10 articles that met the inclusion criteria were retained for the review (Table 1) . 
CT prevalence and patient groups from the literature review
The 10 articles included in the review yielded a CT prevalence ranging from 2.9% to 33%. The highest prevalence was observed among symptomatic men attending STI clinics in Moscow (Renton et al. 2008) Petersburg. More than half (7/10) of the included studies featured populations with STI comorbidities (HIV, gonorrhea) presenting in healthcare settings such as STI clinics and suffering from genitourinary symptoms (Shalepo et al. 2006; Renton et al. 2008; Shipitsyna et al. 2009 Shipitsyna et al. , 2012 Taylor-Robinson et al. 2009; Berle et al. 2012; Pace et al. 2012) . Only two articles included in this review contained data from population screening (Shipitsyna et al. 2007; Berle et al. 2012) . Most of the studies were performed in the western, most populated, part of Russia. More than half (6/10) of the articles included in the review originated from St. Petersburg and the neighboring region of Leningrad Oblast (Shalepo et al. 2006; Shipitsyna et al. 2007 Shipitsyna et al. , 2009 Shipitsyna et al. , 2012 Shipitsyna et al. , 2013 Pace et al. 2012) . Two additional studies included in the review were conducted in the region of Moscow (Renton et al. 2008; Taylor-Robinson et al. 2009 ). All of the included studies used PCR to detect CT. Both internationally available tests (i.e. Cobas Amplicor) and domestically developed tests are available in Russia.
CT prevalence from the multicenter study in St. Petersburg
Overall, the prevalence of genital CT infections among people attending urological, gynecological and family planning clinics in St. Petersburg ranged from 3% to 7.3% (Table 2) . Only 1.5% (14/915) of the Russian men in the study reported being MSM, but the prevalence of CT within this small high-risk group was 28.6% (P = 0.0084). Among men attending urological clinics, CT DNA was detected in 3% of urethral samples (Group 1C) and in 5.7% (Group 1A) and 7.3% (Group 1B) of pooled urethral and EPS samples. Among male partners of subfertile couples (Group 3), CT DNA was detected in 6.1% of semen samples; no significant differences in the number of leukocytes, sperm concentration or motility were detected between CT-positive and CT-negative samples. CT DNA was detected in 6.8% of the cervical samples (Group 2).
Risk factors included being symptomatic at the time of testing (P = 0.004, not shown), being younger than 30 years at the time of the study (P = 0.001) and having had more than 10 lifetime sexual partners (P = 0.0014) ( Table 3) . Urethral CT infection was more often detected in MSM (P = 0.0084). Symptoms were more common in CT-positive men (63.6%) than in CT-positive women (28.6%) (P < 0.0001, not shown).
Regarding STIs, HIV was detected in only two MSW, and N. gonorrhea was diagnosed in one MSW (urethra) and one MSM (urethra and anal canal). Current CT detection was not correlated with the history of being treated for CT infection in the past (P = 0.0837).
All samples found to be CT positive by Russian NAATs in St. Petersburg although limited in number (66) were confirmed as true CT positive by the two PCR assays in Amsterdam.
DISCUSSION
This study is the first to summarize the current knowledge on the prevalence of genital CT infections in Russia. In this respect, the data from several clinics, with varying sample sizes and varying modes of recruitment, could be considered as a strength of the study. From the literature review, CT prevalence in Russian populations attending STI clinics was found to range from 2.9% to 33%. In the multicenter study in St. Petersburg, most of the study populations were considered to have a 'low-risk' profile (none of the participants reported engaging in commercial sex or intravenous drug use, the mean age of participants was above 30 years in all groups and prevalences of other STIs were low), and the CT prevalence was found to be about 6%. The risk factors included being younger than 30 years at the time of the study, being symptomatic at the time of testing and being an MSM. 95%CI, 95% confidence interval; CT, Chlamydia trachomatis; MSM, men who have sex with men; MSW, men who have sex with women; OR, odds ratio. a The study populations were considered to have a 'low-risk' profile as none of the participants reported engaging in commercial sex or intravenous drug use, the mean age of participants was above 30 years in all groups, and prevalences of other STIs were low.
This study had several limitations. First, in the systematic literature review the geographical location of the included studies is not representative of Russia as a whole. The results included in this study provide a thorough overview of CT prevalence in predominantly western Russia (except one study in Novosibirsk), but the results cannot be extrapolated to the whole country. The study populations featured in the included articles do not overlap in terms of patient characteristics and testing and diagnostic methods. Most of the studies performed CT testing on specific patient populations, who were overall at a high risk for STIs. Therefore, a meta-analysis based on these patient populations could not be performed, due to these differences in study characteristics. The current multicenter study, unfortunately, cannot be considered as representative for the whole country either: the geographical coverage of the sample population was limited (all five centers were located in St. Petersburg), in addition almost all of the 'low-risk' participants were aware of the alarming (UNAIDS 2010) situation regarding HIV prevalence in Russia and reported they knew their HIV status and many were in STI clinics.
Among important limitations of the multicenter study was the very limited data on CT prevalence in MSM. Although the impact of the stigma on uptake of HIV/STI services has been stressed (Baral et al. 2012) , research on MSM in Russia remains delicate, due to the perceptions and experiences of stigma (US-AID 2010; Niccolai et al. 2013; Wirtz et al. 2014) . Thus, the first data on HIV prevalence (3.5%-6.0%) and risk factors in MSM in St. Petersburg and Moscow, which recently became available (van Griensven et al. 2009; USAID 2010; Baral et al. 2012) , may not reflect the true prevalence. Although we cannot exclude possible bias due to the conservative attitudes to homosexuality in the country, the multicenter study in St. Petersburg presented the first data on the prevalence of CT infection among MSM, who were recruited out of the gay scene (i.e. gay bars, sexual networks, etc.). Although in the study the vast majority of men reported having had sex with only women and only 1.5% of the men were categorized as MSM, strikingly, CT infection was detected in about one quarter of MSM. Routine screening of MSM for STIs can result in a decline in the incidence of CT infections and HIV (Xiridou et al. 2013) , but this might require a less stigmatized approach towards MSM.
Genital CT infection has been reported to increase the risk of HIV acquisition (Wasserheit 1992; Stamm 1999; Chesson and Pinkerton 2000; Røttingen, Cameron and Garnett 2001) , but surprisingly few data were available about HIV prevalence among the studied populations in all reviewed articles. This could be explained by the long-time practice in the country of requiring a medical check-up, which includes obligatory HIV testing in a venereological dispensary, for any job application or in the case of hospitalization.
Testing for CT is a part of diagnostic assessment of individuals applying for fertility treatment in Russia. In the multicenter study, we present the first data on CT DNA detection in 6.1% of semen samples from 'low-risk' men, who reported being in steady relationships for more than 1 year and planned to apply for assisted reproduction services. Importantly, the majority of men had poor knowledge about the transmission routes of CT infections and their sequelae (data not shown). Although the data were collected in 2006-2009, the current CT prevalence may not differ significantly. The current growing numbers of HIV-positive people (UNAIDS 2010), with a reported shift of HIV transmission routes in Russia towards more sexual transmission (Lowndes, Alary and Platt 2003; Abdala et al. 2008; Burchell et al. 2008) , raise concerns about the potential for the increase in HIV transmission from high-risk groups to a more generalized epidemic (Lowndes, Alary and Platt 2003; Abdala et al. 2008; Burchell et al. 2008) .
Our findings support the recently reported lack of significant differences between infertile and fertile men in terms of CT prevalence (Liu et al. 2014) . A significant impact of CT infection on the female reproductive system has been well described (Paavonen and Eggert-Kruse 1999) , but the role of CT infection in male infertility remains controversial. CT has been detected in the semen (Levy et al. 1999) , the fluid of seminal vesicles (Furuya et al. 2004) , EPS (Smelov et al. 2004 ) and prostate tissues (Corradi et al. 1996; Krieger and Riley 2002) , but it is difficult to exclude possible urethral contamination. Epidemiological data have suggested a possible association between past CT infection and male infertility (Karinen et al. 2004) , but the biological significance of CT infection on male infertility is accepted for acute epididymitis and consecutive azoospermia only (Eley and Pacey 2011) , and further studies are needed.
In the detection of CT, NAATs have generally been accepted as the method of choice. Although the use of suboptimal diagnostic techniques was considered a major problem in Russia (Smelov et al. 2009 ), in recent years several domestic diagnostic systems have been developed in the country for the detection of CT DNA and RNA (Domeika et al. 2002; Shalepo et al. 2006) . The total cost of diagnostic CT PCR of one sample, including test kits, consumables, technician's salaries and other related costs, was calculated as US$2.6 (Shipitsyna et al. 2007) . Some of the Russian NAATs have yielded similar levels of reliability compared with some commercially available FDA approved and CE-IVD certified tests, commonly used in the Netherlands (Smelov et al. 2009 ) and Sweden (Shipitsyna et al. 2009 (Shipitsyna et al. , 2012 . These results suggest that the testing and diagnosis methods in place in the studies featured in the literature review comply with the gold standards for CT detection. The domestically produced tests dominate the market and could be used in further studies on CT prevalence. Improvements are still required in the system of case reporting, the training of laboratory personnel and the level of interlaboratory communication (Domeika et al. 2008) .
International cooperation would be of great value, not only in better prevention of CT/STI or HIV acquisition but also for epidemiological purposes and transmission studies, especially given the increasing number of cross-border and overseas trips, which also result in expanding international sexual networks. The emergence of Russian CT serotypes in Finland is indicated by the increased CT seroprevalence in Finnish border towns (Lyytikäinen et al. 2008) . Moreover, although neither CT LGV (lymphogranuloma venereum) infection nor the new 'Swedish' variant of CT (swCT) was detected in St. Petersburg in 2009 (Smelov et al. 2009 ), the first case of swCT was detected in one female sample in Russia in 2009 already (Shipitsyna et al. 2012) . In a study on CT prevalence in selected populations in five countries, the incidence of asymptomatic CT infection in women in St. Petersburg was found to be high (4.9%) (Detels et al. 2011) .
There is currently no vaccine against CT infections, and early detection plays a crucial role in decreasing the numbers of CTinfected people. Novel detection methods and anatomical sites for optimal CT sampling are of high interest. In the multicenter study in St. Petersburg, diverse genital samples obtained in women (cervical swabs) and men (urethral and anal swabs, semen samples and prostate secretion samples) were tested for CT.
No studies on self-collected or home-collected samples for CT testing in Russia have been reported. Cervical (Shalepo et al. 2006; Shipitsyna et al. 2007 Shipitsyna et al. , 2009 Shipitsyna et al. , 2012 Shipitsyna et al. , 2013 Smelov et al. 2009) and, less often, vaginal (Shipitsyna et al. 2009 ) swabs are the specimens of choice in testing women for CT in Russia. The samples are usually obtained by clinicians or trained nurses, because these personnel have relatively low salaries and also because Russian patients expect to interact with healthcare experts (Grau et al. 2013) . In men, first-void urine samples were accepted in the early 1990s for detection of genital CT (Chernesky et al. 1990) and are now recommended for routine detection (Eley 2011) . A non-invasive urine sample contains a high organism load, but male urethral swabs are still a useful alternative (Eley 2011) . In Russia, sampling of the male distal urethra was originally mandatory for culture tests and microscopy. Interestingly, when NAATs became less expensive and more widespread, urethra sampling still remained the most common practice (Shalepo et al. 2006; Shipitsyna et al. 2007 Shipitsyna et al. , 2009 Shipitsyna et al. , 2012 Shipitsyna et al. , 2013 Smelov et al. 2009 ). Semen is another popular sample because it is self-taken and not painful. Moreover, the collection of semen is obligatory for sperm analysis in andrology clinics or fertility centers. This practice allowed us to obtain the data on CT prevalence in the semen samples in the study in St. Petersburg. However, the methodology for the testing of semen for CT has not been approved (Chernesky 2005) and should be studied (Eley 2011; Eley and Pacey 2011) . Interestingly, CT prevalence was higher in the groups where the EPS specimens were pooled with the urethral ones. Testing multiple specimens tends to detect a higher number of CT infections (Vincelette et al. 1999; Schachter et al. 2005; Shalepo et al. 2006) . Potentially, EPS may represent an additional sampling material for the study of CT infection in men, as has been shown for HPV (Smelov et al. 2013) .
In conclusion, the prevalence of genital CT infections may be high among some populations in Russia. While further studies should be focused on high-risk or stigmatized populations, the increase in HIV prevalence among the general population calls for a national program to improve screening programs for CT infection in Russia.
